We are very grateful to the supporters of the 30th International Symposium on ALS/MND, to be held in Perth, Australia on 4-6 December 2019.*
Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and best-in-class muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. A leader in muscle biology research Cytokinetics is developing small molecule drug candidates specifically engineered to impact muscle function and contractility.
*Full list of sponsors will be available in due course.